91ºÚÁÏÍø

In-person class cancellation and work-from-home / Annulation des cours en présentiel et télétravail

Updated: Tue, 03/10/2026 - 17:14
In-person class cancellation and work-from-home / Annulation des cours en présentiel et télétravail. McGILL ALERT! Due to freezing rain all in-person classes and activities on Wednesday, March 11, will be cancelled. Staff are asked not to come to campus tomorrow unless they are required on site by their supervisor to perform necessary functions and activities. See your 91ºÚÁÏÍø email for more information.
...
ALERTE McGILL! En raison de la pluie verglaçante, tous les cours et activités en présentiel prévus pour le mercredi 11 mars sont annulés. Nous demandons au personnel de ne pas se présenter sur le campus demain, à moins que leur superviseur ne leur demande d’être sur place pour accomplir des fonctions ou activités nécessaires au fonctionnement du campus. Pour plus d’informations, veuillez consulter vos courriels de 91ºÚÁÏÍø.

Heather Melichar

Academic title(s): 

Associate Professor

Heather Melichar
Branch: 
Université 91ºÚÁÏÍø
Department: 
Microbiologie et immunologie
Areas of expertise: 
  • Immunity
  • T cells
  • self-tolerance
  • T cell receptors
  • immunotherapy
Biography: 

Dr. Melichar pursued her doctoral studies at the University of Massachusetts Medical School focusing on the molecular mechanisms influencing T cell fate decisions. She then moved to the west coast and began a postdoctoral fellowship at the University of California, Berkeley, where she developed novel platforms to study the development of both murine and human T cells in situ. In 2014, Dr. Melichar established her independent research group at the Maisonneuve-Rosemont Hospital Research Center affiliated with the University of Montreal. After almost 10 years in this position, Dr. Melichar was recruited to the Goodman Cancer Institute at 91ºÚÁÏÍø where her laboratory continues to study the cellular and molecular mechanisms that regulate the development and function of T cells using insights from these studies to improve the efficacy of cellular therapies.

Back to top